BACE1 and Alzheimer disease: Subsequent cleavage of this fragment by γ-secretase produced Aβ40 and Aβ42 peptides, both of which were central to the aggregation of neuritic plaques, and BACE1 activity was recognized as an early biomarker of AD (Nicsanu et al., 2022).